Technetium Tc-99m tilmanocept Completed Phase 4 Trials for Cancer, Breast

IndicationsStatusPurposePhase
CompletedNot Available4
clinicaltrials.gov IdentifierTitleDrugs
NCT02065232Sentinel Lymph Node Mapping Post-Injection Site Pain